Siemens' Diagnostic Products Corporation buy gets Federal Trade Commission all-clear
This article was originally published in Clinica
Executive Summary
Siemens Medical Solutions' proposed $1.86bn acquisition of immunodiagnostics company DPC (Diagnostic Products Corporation) has received the go-ahead from US antitrust authorities.